Literature DB >> 18367118

Sexual intimacy in heterosexual couples after prostate cancer treatment: What we know and what we still need to learn.

Andrea M Beck1, John W Robinson, Linda E Carlson.   

Abstract

Receiving a diagnosis of and treatment for prostate cancer often results in significant physical side-effects and associated psychosocial stressors that can interfere with the experience of sexual intimacy for couples. Despite the fact that prostate cancer affects mainly older men, the maintenance of sexual intimacy is an important issue to consider, as the majority of older adults continue to value, engage in, and enjoy sexual activity throughout their lives. While the current research identifies the challenges that many men face, little is known about the strategies that couples use to successfully maintain sexual intimacy after prostate cancer treatment. In this review article, the existing literature on sexual intimacy after prostate cancer is reviewed, a critical analysis of current limitations in our knowledge and understanding is provided, and directions for further research are suggested.

Entities:  

Mesh:

Year:  2008        PMID: 18367118     DOI: 10.1016/j.urolonc.2007.11.032

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  12 in total

1.  The effects of partnered exercise on physical intimacy in couples coping with prostate cancer.

Authors:  Karen S Lyons; Kerri M Winters-Stone; Jill A Bennett; Tomasz M Beer
Journal:  Health Psychol       Date:  2015-10-12       Impact factor: 4.267

2.  What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples' sexual recovery after surgery for prostate cancer.

Authors:  Daniela Wittmann; Marsha Carolan; Barbara Given; Ted A Skolarus; Heather Crossley; Lawrence An; Ganesh Palapattu; Patricia Clark; James E Montie
Journal:  J Sex Med       Date:  2014-10-31       Impact factor: 3.802

3.  Multilevel modeling in psychosomatic medicine research.

Authors:  Nicholas D Myers; Ahnalee M Brincks; Allison J Ames; Guillermo J Prado; Frank J Penedo; Catherine Benedict
Journal:  Psychosom Med       Date:  2012-10-29       Impact factor: 4.312

4.  How often do head and neck cancer patients raise concerns related to intimacy and sexuality in routine follow-up clinics?

Authors:  S N Rogers; P Hazeldine; K O'Brien; D Lowe; B Roe
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-14       Impact factor: 2.503

5.  Sexual problems, communication patterns, and depressive symptoms in couples coping with metastatic breast cancer.

Authors:  Kathrin Milbury; Hoda Badr
Journal:  Psychooncology       Date:  2012-05-04       Impact factor: 3.894

6.  A randomized trial of a minimal intervention for sexual concerns after cancer: a comparison of self-help and professionally delivered modalities.

Authors:  Janette Perz; Jane M Ussher
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

7.  Perceived causes and consequences of sexual changes after cancer for women and men: a mixed method study.

Authors:  Jane M Ussher; Janette Perz; Emilee Gilbert
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

8.  Suitable sexual health care according to men with prostate cancer and their partners.

Authors:  Lorena A Grondhuis Palacios; Esmée M Krouwel; Brenda L den Oudsten; Marjolein E M den Ouden; Gert Jan Kloens; Grethe van Duijn; Hein Putter; Rob C M Pelger; Henk W Elzevier
Journal:  Support Care Cancer       Date:  2018-06-07       Impact factor: 3.603

9.  Psychosexual experiences of men following radiotherapy for prostate cancer in Johannesburg, South Africa.

Authors:  Matheko N Phahlamohlaka; Sibusiso Mdletshe; Heather Lawrence
Journal:  Health SA       Date:  2018-10-09

10.  Constructions of sex and intimacy after cancer: Q methodology study of people with cancer, their partners, and health professionals.

Authors:  Janette Perz; Jane M Ussher; Emilee Gilbert
Journal:  BMC Cancer       Date:  2013-05-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.